Butyrylcholinesterase Nuclear envelope Myopathies Biomarker Cardiomyopathy AAV VECTOR Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS CSF protein Dystrophine Errance diagnostique C2C12 LMNA gene Autophagosome maturation Muscular dystrophy MD Becker muscular dystrophy CRISPR Lamin A/C Actionable gene Muscle MRI Acetyltransferase Rare diseases Angiotensin-converting enzyme inhibitors Muscle biopsy COL6A1 LMNA-related congenital muscular dystrophy Maladies rares et orphelines COL1A1 Connective tissue Alternative splicing Emerin Ehlers‐Danlos Syndrome Maladies rares Next generation sequencing Diagnosis Muscular dystrophy A-type lamins Heart failure Joint laxity Myotubes Allele-specific silencing therapy Lamin A/C LMNA gene Cardiac conduction system Duchenne muscular dystrophy Clinical trial INPP5K Rare neuromuscular diseases Neuromuscular diseases Actionability Cancer Myogenesis POPDC1 Patient registry Angiotensin-converting enzyme inhibitor IPSC Therapy A-type lamin COVID-19 LGMD Myologie Biological sciences Mutations Hypermobile EDS Lamins Titin Allele-specific silencing Centronuclear myopathy Base de données FAIR Heart C elegans Emery-Dreifuss muscular dystrophy Dynamin 2 Dilated cardiomyopathy Laminopathie Lamin A/C nuclei Myopathy Treatment COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Calcium handling Laminopathy Adult SMA RNA interference Skeletal muscle Treatment delay LMNA CMTX Dystrophie musculaire Congenital muscular dystrophy Cardiology BVES BiP Muscle Laminopathies Regeneration AAV Cancer biomarkers Gene therapy GNE Allele‐specific silencing therapy Exome Mouse